PillRx only · Tablet, Film Coated, Extended Release · Oral
Glipizide
Glipizide
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.101
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
6
Active US suppliers
49%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
95K
Rx · 2026 Q1
6.2M
Units dispensed
-27%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 11 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 8 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 7 | SUPPLYING |
| A-S Medication Solutions | unknown | 5 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 5 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 3 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.